Guy’s and St Thomas’ NHS Foundation Trust’ and King’s College London will set up a new HealthTech Research Centre focussing on cardiovascular and respiratory medicine.
The centre, based at St Thomas’ Hospital, will work with industry and academic partners as a new “one stop shop” to develop new technologies, medical devices and digital solutions to benefit patients.
It will be one of 14 new HealthTech Research Centres across England which received nearly £42 million in total from the NIHR (National Institute for Health and Care Research).
The cardio-respiratory HealthTech Research Centre will focus on 4 themes:
- cardiovascular diseases in adults
- technologies for children with congenital heart diseases
- cardiovascular interventions
- respiratory medicine
In addition to developing technologies to support and promote the use of health-tech at home, the centre will develop training for the next generation of health-tech innovators and researchers.
Amedeo Chiribiri MD, PhD, FHEA, FSCMR, consultant cardiologist at Guy’s and St Thomas’ and professor of cardiovascular imaging at King’s College London, is co-director of the new HealthTech Research Centre.
Prof. Chiribiri said: “I am proud to announce the NIHR cardiovascular and respiratory HealthTech Research Centre at Guy’s and St Thomas’ and King’s College London. With the infrastructure provided by the centre, we will support the development of new technologies, growing health-tech in the UK and helping people live more independent and healthier lives for longer.”
Rachel Clough, consultant vascular surgeon at Guy’s and St Thomas’ and clinical senior lecturer in surgical and interventional engineering at King’s College London, is also the HealthTech Research Centre co-director. Miss Clough added: “Building on the extensive expertise in the management of cardiovascular diseases, respiratory conditions, biomedical and clinical engineering, we are able to offer a centre based in the heart of London but with national remit, that will foster and accelerate the translation to bedside of new promising technologies for the benefit of patients, the NHS, and the British economy.”
Dr. Didi (Emmanuel) Akinluyi, chief biomedical engineer at Guy’s and St Thomas’ and deputy director of the centre, said: “Our geographical location is one of the keys to the success of our research, since Lambeth, Southwark, Kensington and Chelsea as a whole encompass some of the most diverse populations in the UK. Our strategy for public and patient engagement and equality, diversity and inclusion are designed to work with the local community and with our patients.”
